Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan
- 22 June 2010
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 33 (S2) , 295-305
Abstract
In Taiwan, during the period March 2000 to June 2009, 1,495,132 neonates were screened for phenylketonuria (PKU) and homocystinuria (HCU), and 1,321,123 neonates were screened for maple syrup urine disease (MSUD), methylmalonic academia (MMA), medium‐chain acyl‐coenzyme A (CoA) dehydrogenase (MCAD) deficiency, isovaleric academia (IVA), and glutaric aciduria type 1 (GA‐1) using tandem mass spectrometry (MS/MS). In a pilot study, 592,717 neonates were screened for citrullinemia, 3‐methylcrotonyl‐CoA carboxylase deficiency (3‐MCC) and other fatty acid oxidation defects in the MS/MS newborn screening. A total of 170 newborns and four mothers were confirmed to have inborn errors of metabolism. The overall incidence was approximately 1/5,882 (1/6,219 without mothers). The most common inborn errors were defects of phenylalanine metabolism [five classic PKU, 20 mild PKU, 40 mild hyperphenylalaninemia (HPA), and 13 6‐pyruvoyl‐tetrahydropterin synthase (PTPS) deficiency]. MSUD was the second most common amino acidopathy and, significantly, most MSUD patients (10/13) belonged to the Austronesian aboriginal tribes of southern Taiwan. The most frequently detected among organic acid disorders was 3‐MCC deficiency (14 newborns and four mothers). GA‐1 and MMA were the second most common organic acid disorders (13 and 13 newborns, respectively). In fatty acid disorders, five carnitine transport defect (CTD), five short‐chain acyl‐CoA dehydrogenase deficiency (SCAD), and two medium‐chain acyl‐CoA dehydrogenase (MCAD) deficiency were confirmed. This is the largest case of MS/MS newborn screening in an East‐Asian population to date. We hereby report the incidences and outcomes of metabolic inborn error diseases found in our nationwide MS/MS newborn screening program.Keywords
This publication has 28 references indexed in Scilit:
- Diagnoses of newborns and mothers with carnitine uptake defects through newborn screeningMolecular Genetics and Metabolism, 2010
- Newborn Population Screening for Classic Homocystinuria by Determination of Total Homocysteine from Guthrie CardsThe Journal of Pediatrics, 2010
- Maple syrup urine disease (MSUD)—Clinical profile of 47 Filipino patientsJournal of Inherited Metabolic Disease, 2008
- Guideline for the diagnosis and management of glutaryl‐CoA dehydrogenase deficiency (glutaric aciduria type I)Journal of Inherited Metabolic Disease, 2007
- Pitfalls of neonatal screening for very-long-chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometryThe Journal of Pediatrics, 2006
- The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005Journal of Inherited Metabolic Disease, 2006
- A novel deletion creating a new terminal exon of the dihydrolipoyl transacylase gene is a founder mutation of Filipino maple syrup urine diseaseMolecular Genetics and Metabolism, 2004
- Mutation spectrum in Taiwanese patients with phenylalanine hydroxylase deficiency and a founder effect for the R241C mutationHuman Mutation, 2004
- Expanded Newborn Screening for Inborn Errors of Metabolism by Electrospray Ionization-Tandem Mass Spectrometry: Results, Outcome, and ImplicationsPediatrics, 2003
- Glutaric Acidemia, Type I, Missed by Newborn Screening in an Infant With Dystonia Following Promethazine AdministrationPediatrics, 2001